內視鏡狹窄管理設備市場- 產品（支架、球囊擴張器、球囊充氣裝置、探條擴張器）、應用（食道、結腸、膽道）、最終用戶（醫院、門診手術中心） - 全球預測（ 2024 - 2032）

內視鏡狹窄管理設備市場規模預計在2024 年至2032 年間將以5.8% 的複合年成長率成長。治療解決方案。根據美國國家醫學圖書館的資料，到2030 年，歐洲和美國將有超過700 萬人患有發炎性腸道疾病(IBD)。和安全性，從而提高採用率。

對胃腸道疾病的日益認知和早期診斷也刺激了對這些設備的需求。全球人口老化更容易出現此類疾病，這也增加了產品的部署。這些設備提供的微創手術可以減少恢復時間並改善患者的治療效果，這也使它們成為首選。有利的監管批准、不斷增加的醫療保健支出和報銷政策進一步推動了市場的成長。

整個市場分為產品、應用、最終用戶和地區。

從產品來看，球囊擴張器領域的內視鏡狹窄管理設備市場將在 2024 年至 2032 年間以顯著速度成長，因為它們能夠有效地以微創方式治療狹窄。這些設備可以精確擴張胃腸道狹窄區域，同時減少手術需求並促進患者復原。快速進步正在提高其安全性和有效性。胃腸道疾病的盛行率不斷上升，以及醫療保健專業人員對先進治療方案的認知不斷提高，正在推動產品需求。

由於克隆氏症和大腸直腸癌等大腸直腸疾病發生率的上升，預計到 2032 年，結腸應用領域的內視鏡狹窄管理設備產業將以顯著速度成長。日益提高的認知和早期診斷正在推動對有效治療方案的需求。內視鏡設備的技術發展正在提高精度和患者治療效果。對微創手術的日益青睞和人口老化的不斷成長將進一步推動該細分市場的成長。

從地區來看，由於胃腸道疾病盛行率上升、醫療保健支出增加以及先進醫療技術的普及，亞太地區內視鏡狹窄管理設備市場將在 2024 年至 2032 年間呈現強勁成長。對胃腸道疾病的認知不斷提高以及早期診斷正在推動該地區對這些設備的需求。人口老化和微創手術的日益普及也將推動區域產業的進步。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 內視鏡狹窄治療設備的持續技術進步
    • 導致狹窄的疾病/病症盛行率不斷增加
    • 提高對狹窄早期診斷的認知
    • 使用內視鏡進行微創手術的增加
  • 產業陷阱與挑戰
    • 設備核准的嚴格監管要求
    • 使用球囊擴張和支架的內視鏡手術成本高昂
• 成長潛力分析
• 監管環境
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

• 主要趨勢
• 支架
  • 金屬支架
  • 塑膠支架
  • 可生物分解支架
• 球囊擴張器
  • 球囊擴張器導管
  • 氣球充氣裝置
• 探條擴張器
• 其他產品

第 6 章：市場估計與預測：按應用分類，2021 - 2032

• 主要趨勢
• 食道
• 結腸
• 幽門
• 膽道
• 其他應用

第 7 章：市場估計與預測：按最終用戶分類，2021 - 2032 年

• 主要趨勢
• 醫院
• 門診手術中心
• 其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

• 主要動向：按地區
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 歐洲其他地區
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 中東和非洲其他地區

第 9 章：公司簡介

• Boston Scientific Corporation
• Olympus Corporation
• CONMED Corporation
• Cook Medical Inc.
• Becton, Dickinson and Company
• Merit Medical Systems
• Medi-Globe GmbH
• PanMed Us
• HOBBS MEDICAL, INC.
• Micro-Tech (Nanjing) Co., Ltd
• Steris plc (Diagmed Healthcare)
• Taewoong Medical Co., Ltd.

Endoscopic Stricture Management Device Market size is projected to grow at 5.8% CAGR between 2024 and 2032. The rising prevalence of gastrointestinal disorders, such as Crohn's disease and esophageal strictures, is necessitating several effective treatment solutions. According to data from the National Library of Medicine, more than 7 million people in Europe and the U.S. will be suffering from inflammatory bowel diseases (IBD) by 2030. Significant advancements in endoscopy are enhancing the precision, efficacy, and safety of stricture management, leading to increasing adoption rates.

The growing awareness and early diagnosis of gastrointestinal conditions is also spurring the demand for these devices. The aging global population, which is more prone to such disorders is also increasing the product deployment. Minimally invasive procedures offered by these devices to reduce recovery times and improve patient outcomes is also making them a preferred choice. The favorable regulatory approvals, increasing healthcare expenditure, and reimbursement policies are further driving the market growth.

The overall market is segregated into product, application, end-user, and region.

Based on product, the endoscopic stricture management device market from the balloon dilators segment will grow at notable pace between 2024 and 2032, on account of their effectiveness in treating strictures with minimal invasiveness. These devices offer precise dilation of narrowed areas in the gastrointestinal tract while reducing the need for surgery and enhancing patient recovery. Rapid advancements are improving their safety and efficacy. The increasing prevalence of gastrointestinal disorders and the rising awareness among healthcare professionals about advanced treatment options are fueling the product demand.

Endoscopic stricture management device industry from the colonic application segment is estimated to grow at significant rate up to 2032, led by the rising incidence of colorectal diseases, such as Crohn's disease and colorectal cancer. The increasing awareness and early diagnosis are driving the demand for effective treatment options. Technological developments in endoscopic devices are improving precision and patient outcomes. The rising preference for minimally invasive procedures and the growing aging population will further boost the segment growth.

Regionally, the Asia Pacific endoscopic stricture management device market will showcase strong gains between 2024 and 2032, driven by the rising prevalence of gastrointestinal disorders, increasing healthcare expenditure, and expanding access to advanced medical technologies. The growing awareness and early diagnosis of gastrointestinal conditions is boosting the demand for these devices in the region. The aging population and the increasing adoption of minimally invasive procedures will also push the regional industry progression.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Ongoing technological advances in endoscopic stricture management devices
    • 3.2.1.2 Increasing prevalence of diseases/disorders leading to strictures
    • 3.2.1.3 Increasing awareness towards early diagnosis of strictures
    • 3.2.1.4 Increase in minimally invasive surgical procedures using endoscopes
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory requirements for device approval
    • 3.2.2.2 High cost of endoscopic surgical procedures using balloon dilation and stents
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Million)

• 5.1 Key trends
• 5.2 Stents
  • 5.2.1 Metal stents
  • 5.2.2 Plastic stents
  • 5.2.3 Biodegradable stents
• 5.3 Balloon dilators
  • 5.3.1 Balloon dilator catheters
  • 5.3.2 Balloon inflation devices
• 5.4 Bougie dilators
• 5.5 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Million)

• 6.1 Key trends
• 6.2 Esophageal
• 6.3 Colonic
• 6.4 Pyloric
• 6.5 Biliary
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End User, 2021 - 2032 ($ Million)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgery centers
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Boston Scientific Corporation
• 9.2 Olympus Corporation
• 9.3 CONMED Corporation
• 9.4 Cook Medical Inc.
• 9.5 Becton, Dickinson and Company
• 9.6 Merit Medical Systems
• 9.7 Medi-Globe GmbH
• 9.8 PanMed Us
• 9.9 HOBBS MEDICAL, INC.
• 9.10 Micro-Tech (Nanjing) Co., Ltd
• 9.11 Steris plc (Diagmed Healthcare)
• 9.12 Taewoong Medical Co., Ltd.